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Introduction
Protein-energy malnutrition (PEM) is a common clinical
manifestation of patients with liver cirrhosis.1-7 Lautz et al.8
reported that 65% of patients with liver cirrhosis showed
some signs of PEM as indicated by low body cell mass, re-
duced serum albumin concentrations, or abnormal skinfold
thickness. This is mainly due to abnormal fuel metabolism
including visceral and skeletal muscle protein-catabolic state,9
increased fat oxidation, and decreased glucose oxidation.10
This condition is associated with a poor prognosis and re-
duced survival.9,11 Therefore, accurate assessments of nutri-
tional status such as measurement of energy expenditure
may be of clinical value in cases of liver cirrhosis.12, 13
Indirect calorimetry is an established method for esti-
mating energy malnutrition, despite being expensive and
requiring training to use. Resting energy expenditure (REE)
and respiratory quotient (RQ) are the main parameters con-
sidered when evaluating energy metabolism by indirect
calorimetry.11 RQ has been reported to decrease after an
overnight fast in cirrhotic patients in many studies, but
whether increased basal or resting energy expenditure is a
constant feature in liver cirrhosis remains controversial.1, 3
In the present study, we aimed to investigate the protein
and energy metabolic statuses, including the measurement
of serum albumin concentration, and the measurement of
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Protein-energy malnutrition (PEM) is frequently seen in patients with liver cirrhosis. This condition is associated with a poor
prognosis and reduced survival. We investigated the protein and energy metabolic status, including serum albumin concentra-
tion, and resting energy expenditure (REE) and respiratory quotient (RQ) measured by indirect calorimetry in 23 patients with
liver cirrhosis (8 men and 15 women; mean age, 60.3 years). The median value of %REE (measured REE / predicted REE)
was highest in Child-Pugh grade A and lowest in grade C, and the range of RQ tended to be highest in Child-Pugh grade A
and lowest in grade C, although there were not statistically significant (p=0.871 and 0.664, respectively). Serum triglyceride
concentration was significantly lower in patients who had an RQ less than 0.85 than in patients who had an RQ of 0.85 or
more, and free fatty acid tended to be higher in patients who had an RQ less than 0.85 than in patients who had an RQ of 0.85
or more. Of the 23 patients, 78.3% were in a state of protein and/or energy malnutrition and 47.8% had PEM. Our results sug-
gest that %REE and RQ were not significantly associated with liver function, but the oxidation rate of fat was increased in ad-
vanced liver cirrhosis. A longitudinal study in a large population is needed to determine the efficacy of %REE and RQ meas-
urements for adequate nutritional treatment and improvement of patient outcome.
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Of the 150 patients who were admitted to the Department
of Gastroenterology and Hepatology, Nagasaki University
Hospital, Japan, and who also underwent indirect calorimetry
between April 2008 and October 2009, 23 patients with
liver cirrhosis (8 men and 15 women; mean age, 60.3 ±
10.3 years) were included in the present study. The medical
records of the 23 patients with liver cirrhosis were collected
and analyzed. The collected data included sex, age, etiology
of liver cirrhosis, Child-Pugh grade (Table 1),14,15 height,
body weight, history of alcohol intake, associated disease
such as hypertension, diabetes mellitus, and esophageal
varices, and history of branched-chain amino acid (BCAA)
treatment. The laboratory data such as peripheral platelet
count (PLT), C-reactive protein (CRP), serum levels of al-
bumin (ALB), total bilirubin (TB), aspartate aminotransferase
(AST), alanine aminotransferase (ALT), total cholesterol
(TC), triglyceride (TG), free fatty acid (FFA), blood urea
nitrogen (BUN), creatinine (Cr), sodium (Na), potassium
(K), chloride (Cl), calcium (Ca), and phosphorus (P), fast-
ing blood glucose (FBG), immunoreactive insulin (IRI),
prothrombin time (PT), ammonia (NH3), and BCAA to ty-
rosine ratio (BTR) were also collected. Standard biochemi-
cal tests were performed on a multichannel autoanalyzer.
The history of alcohol intake was divided into two groups
as follows: drinker (at least 70 g/day of alcohol intake for
more than 5 years) and non- or light-drinker (less than 70
g/day of alcohol intake for up to 5 years). The diagnosis of
liver cirrhosis was based on a compatible clinical history,
radiological studies, and/or histopathological examination
when available. Patients who were seropositive for hepatitis
B surface antigen (HBsAg) were classified as "hepatitis B
virus (HBV)-related"; those who were seropositive for anti-
body to hepatitis C virus (anti-HCV) as "HCV-related";
those who were drinkers and seronegative for HBsAg and
anti-HCV as "alcoholic"; and those who were non- or light-
drinkers and seronegative for HBsAg and anti-HCV as
"others". The body mass index (BMI) was calculated as
body weight (kg) divided by height squared (m2).
Indirect calorimetry
Indirect calorimetry was carried out in the morning after
overnight bed rest and fasting using a Vmax SPECTRA
29n calorimeter (Cardinal Health 207. Inc., Dublin, OH,
USA). The equipment was calibrated at the start of each
measurement in accordance with the manufacturer's in-
structions. About 3 or 4 minutes after the patient rested in
the supine position in a rigid canopy (placed over the head
in which the patient respires freely), oxygen consumption
per minute (VO2) and carbon dioxide production per minute
(VCO2) were measured during a period of at least 15 min-
utes. Resting energy expenditure (REE) was calculated
using the modified Weir formula16 as follows: REE (kcal/-
day) = [3.9 x VO2 (L/min) + 1.1 x VCO2 (L/min)] x 1440.
Respiratory quotient (RQ) was calculated as follows: RQ =
VCO2 (L/min) / VO2 (L/min). The predicted REE was esti-
mated from the Harris-Benedict equations17 as follows:
basal metabolic rate (BMR) (kcal/day) for men = 66.47 +
13.75 x body weight (kg) + 5.00 x height (cm) - 6.75 x age
(years). The BMR (kcal/day) for women = 655.10 + 9.56 x
body weight (kg) + 1.85 x height (cm) - 4.68 x age (years).
The %REE was calculated as follows: %REE = measured
REE (kcal/day) / predicted REE (kcal/day).
Ethical consideration
This study was performed according to the principles of
the Declaration of Helsinki. The study protocol was ap-
proved by the Ethical Committee of University of
Nagasaki. Informed consent was obtained from all partici-
pants in Nagasaki University Hospital.
Statistical analysis
Data were expressed as mean ± standard deviation (SD)
or as median (range). Differences between groups were
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Table 1. Definition and criteria of Child-Pugh classification
Definition and criteria of encephalopathy and prothrombin time are modi-
fied according to the Liver Cancer Study Group of Japan.14,15 The scores
for all findings are totaled, and a final score of 5-6 is assigned a Child-
Pugh grade A, score of 7-9 is grade B, and score of 10-15 is grade C.
Refer to the text in the Patients and Methods section for abbreviations.
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tested for statistical significance using the two-tailed Mann-
Whitney U-test, Kruskal-Wallis test followed by Bonferroni's
multiple comparison test, chi-square test, or Fisher's exact
probability test. All data analyses were performed using
IBM SPSS statistics software, version 17.0 (IBM Co.,
Somers, NY) on a computer with a Windows operating sys-
tem. A p-value less than 0.05 was considered statistically
significant.
Results
Clinical characteristics of 23 patients with liver cirrhosis
The clinical features of 23 patients with liver cirrhosis
are shown in Table 2. The etiology of liver cirrhosis was
"HBV-related" in 5 patients, "HCV-related" in 9 patients,
"alcoholic" in 4 patients, and "others" in 5 patients. Of the
5 patients who were categorized as "others", 3 were diag-
nosed as primary biliary cirrhosis (PBC), one as autoimmune
hepatitis (AIH), and one as PBC-AIH overlapping syn-
7
Feature Number examined Result
Men/women 23 8/15
Age (years) 23 64 (34-76)
Etiology* (HBV/HCV/alcohol/others) 23 5/9/4/5
Child-Pugh grade (A/B/C) 23 8/7/8
Height (m) 23 1.53 (1.42-1.75)
Body weight (kg) 23 56.4 (37.0-90.0)
BMI (kg/m2) 23 24.0 (16.4-29.7)
REE (kcal/day) 23 1163 (956-1667)
%REE 23 100 (81-126)
RQ 23 0.83 (0.72-1.02)
VO2 (L/min) 23 0.17 (0.13-0.24)
VCO2 (L/min) 23 0.14 (0.12-0.20)
PLT (x103/mm3) 23 12.5 (3.1-35.0)
CRP (mg/dL) 22 0.25 (0.02-1.15)
ALB (g/dL) 23 3.1 (2.3-4.3)
TB (mg/dL) 23 1.4 (0.4-26.7)
AST (IU/L) 23 42 (14-156)
ALT (IU/L) 23 29 (8-73)
FBG (mg/dL) 16 104 (62-166)
IRI (μU/mL) 11 8.8 (3.5-107.3)
TC (mg/dL) 14 134 (87-377)
TG (mg/dL) 16 84 (23-314)
FFA (mEq/L) 13 0.73 (0.25-1.57)
BUN (mg/dL) 23 17 (4-66)
Cr (mg/dL) 23 0.72 (0.42-2.09)
Na (mEq/L) 23 137 (125-143)
K (mEq/L) 23 4.0 (3.3-4.9)
Cl (mEq/L) 23 104 (91-108)
Ca (mg/dL) 13 8.7 (8.2-9.8)
P (mg/dL) 10 3.3 (1.9-4.6)
PT (%) 23 64 (32-120)
NH3 (μg/dL) 18 77 (34-174)
BTR 16 3.06 (1.32-8.85)
History of alcohol intake (non- or light-drinker/drinker/unknown) 23 15/5/3
Diabetes mellitus (absent/present) 23 12/11
Hypertension (absent/present) 23 16/7
Esophageal varices (absent/present) 23 12/11
BCAA treatment (absent/present) 23 13/10
*HBV,hepatitis B virus-related; HCV, hepatitis C virus-related.
Refer to the text in the Patients and Methods section for other abbreviations.
Age, height, body weight, body mass index, metabolic parameters, peripheral platelet count, and blood biochemical parameters are
expressed as median (range).
Table 2. Clinical characteristics of 23 patients with liver cirrhosis
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drome. Mild hepatic encephalopathy occurred in only one
patient. Minimum ascites was observed in 2 patients and
moderate ascites was detected in 10 patients. Serum TB
was 2.0-3.0 mg/dL in one patient and more than 3.0 mg/dL
in 6 patients. Serum ALB was 2.8-3.5 g/dL in 9 patients
and less than 2.8 g/dL in 6 patients. Prothrombin time was
40%-70% in 14 patients and less than 40% in 2 patients.
The aggregate Child-Pugh score ranged from 5 to 13 points
and the median value was 8. Overall, 8 patients were cate-
gorized as Child-Pugh grade A, 7 patients as grade B, and
8 patients as grade C.
Comparison of clinical features among patients who were
categorized as Child-Pugh grade A, B, and C
Except for the laboratory findings included in Child-Pugh
classification such as serum TB, ALB, and PT, there were
significant differences in serum Na, Ca, TC, and frequency
of receiving BCAA treatment among patients who were
categorized as Child-Pugh grade A, B, and C. Particularly,
BCAA treatment was more common in patients categorized
as Child-Pugh grade C (Table 3). There were no significant
differences in %REE and RQ among patients who were
8
Refer to the text in the Patients and Methods section and Table 2 for abbreviations.
Age, height, body weight, body mass index, metabolic parameters, peripheral platelet count, and blood biochemical parameters are expressed as median
(range)
Feature Grade A Grade B Grade C P
Men/women 3/5 3/4 2/6 0.866
Age (years) 65 (46-76) 65 (49-72) 51 (34-65) 0.095
Etiology (HBV/HCV/alcohol/others) 2/3/1/2 1/4/1/1 2/2/2/2 0.971
Height (m) 1.52 (1.42-1.64) 1.55 (1.43-1.67) 1.52 (1.45-1.75) 0.675
Body weight (kg) 56.1 (47.2-63.5) 59.0 (43.5-68.5) 56.7 (37.0-90.0) 0.777
BMI (kg/m2) 23.2 (20.7-29.4) 24.0 (18.1-29.7) 26.0 (16.4-29.4) 0.838
REE (kcal/day) 1164 (956-1300) 1138 (1021-1667) 1180 (1100-1578) 0.450
%REE 103 (90-110) 101 (81-118) 97 (81-126) 0.871
RQ 0.83 (0.78-1.02) 0.84 (0.76-0.87) 0.82 (0.72-0.92) 0.664
VO2 (L/min) 0.17 (0.13-0.19) 0.16 (0.15-0.24) 0.17 (0.15-0.23) 0.474
VCO2 (L/min) 0.14 (0.13-0.17) 0.13 (0.12-0.20) 0.14 (0.12-0.18) 0.646
PLT (x103/mm3) 15.3 (6.4-31.2) 13.6 (6.6-35.0) 9.1 (3.1-17.6) 0.204
CRP (mg/dL) 0.15 (0.02-1.15) 0.23 (0.05-0.25) 0.43 (0.17-0.73) 0.227
ALB (g/dL) 3.7 (2.9-4.3) 3.1 (2.7-3.6) 2.8 (2.3-3.2) 0.003
TB (mg/dL) 0.9 (0.4-1.4) 0.9 (0.5-1.4) 3.9 (1.5-26.7) 0.001
AST (IU/L) 39 (14-74) 43 (18-63) 53 (23-156) 0.342
ALT (IU/L) 30 (10-53) 32 (8-39) 28 (13-73) 0.742
FBG (mg/dL) 111 (62-133) 93.5 (79-166) 118 (72-144) 0.934
IRI (μU/mL) 13.3 (4.2-15.0) 6.7 (3.5-107.3) 16.6 (8.6-24.6) 0.736
TC (mg/dL) 177 (102-377) 114 (105-174) 95 (87-102) 0.039
TG (mg/dL) 81 (63-314) 84 (48-117) 114 (23-125) 0.972
FFA (mEq/L) 0.75 (0.29-1.57) 0.55 (0.25-1.03) 0.86 (0.61-1.54) 0.453
BUN (mg/dL) 17 (4-23) 16 (10-66) 17 (5-48) 0.856
Cr (mg/dL) 0.74 (0.42-1.28) 0.85 (0.56-1.97) 0.62 (0.43-2.09) 0.519
Na (mEq/L) 138 (136-140) 138 (132-139) 132 (125-143) 0.031
K (mEq/L) 4.3 (3.3-4.7) 3.9 (3.3-4.9) 3.9 (3.5-4.9) 0.606
Cl (mEq/L) 104 (99-107) 105 (98-108) 100 (91-106) 0.061
Ca (mg/dL) 9.3 (8.9-9.8) 8.4 (8.2-8.7) 8.6 (8.5-9.2) 0.015
P (mg/dL) 4.3 (3.4-4.6) 3.3 (2.6-3.5) 2.7 (1.9-3.0) 0.060
PT (%) 84 (57-120) 64 (45-70) 46 (32-67) 0.002
NH3 (μg/dL) 71 (60-105) 115 (62-174) 83 (34-145) 0.411
BTR 3.44 (2.86-7.26) 3.11 (2.73-4.64) 2.75 (1.32-8.85) 0.452
History of alcohol intake
(non- or light-drinker/drinker/unknown) 5/1/2 6/0/1 4/4/0 0.123
Diabetes mellitus (absent/present) 3/5 5/2 4/4 0.508
Hypertension (absent/present) 4/4 4/3 8/0 0.073
Esophageal varices (absent/present) 4/4 4/3 4/4 1.000
BCAA treatment (absent/present) 8/0 4/3 1/7 0.001
Table 3. Comparison of clinical features among patients who are categorized as Child-Pugh grade A, B, and C
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categorized as Child-Pugh grade A, B, and C, but the me-
dian value of %REE was highest in Child-Pugh grade A
and lowest in grade C. Moreover, the range of RQ tended
to be highest in Child-Pugh grade A and lowest in grade C,
although there were not statistically significant (Fig. 1).
Comparison of clinical features between patients who had
a respiratory quotient less than 0.85 and patients who had
a respiratory quotient of 0.85 or more
Because an RQ of 0.85 was reported to be the point at
which substrate for thermogenesis turned from carbohy-
drate dominant (RQ>0.85) to fat dominant (RQ<0.85), and
survival rate was significantly lower in patients with low
RQ (<0.85) than in patients with scores above 0.85,3 we
conducted a comparison of clinical features between pa-
tients who had an RQ less than 0.85 and patients who had
RQ of 0.85 or more (Table 4). Height was significantly
higher in patients who had an RQ less than 0.85 than in pa-
tients who had an RQ of 0.85 or more. Serum TG was sig-
nificantly lower in patients who had an RQ less than 0.85
than in patients who had an RQ of 0.85 or more, and FFA
9
Refer to the text in the Patients and Methods section and Table 2 for abbreviations.
Age, height, body weight, body mass index, metabolic parameters, peripheral platelet count, and blood biochemical parameters are expressed as median
(range).
Feature RQ 0.85 RQ 0.85 P
Men/women 7/7 1/8 0.086
Age (years) 62.5 (34-76) 64 (46-72) 0.728
Etiology (HBV/HCV/alcohol/others) 4/7/3/0 1/2/1/5 0.009
Child-Pugh grade (A/B/C) 5/4/5 3/3/3 0.484
Height (m) 1.55 (1.45-1.75) 1.46 (1.42-1.67) 0.012
Body weight (kg) 56.1 (43.5-90.0) 59.0 (37.0-68.5) 0.753
BMI (kg/m2) 22.2 (18.1-29.4) 25.7 (16.4-29.7) 0.176
REE (kcal/day) 1163 (1021-1667) 1179 (956-1402) 0.614
%REE 101 (81-126) 98 (90-111) 0.592
VO2 (L/min) 0.17 (0.15-0.24) 0.17 (0.13-0.20) 0.256
VCO2 (L/min) 0.14 (0.12-0.20) 0.14 (0.13-0.17) 0.313
PLT (x103/mm3) 12.2 (3.1-35.0) 13.0 (6.4-31.2) 0.925
CRP (mg/dL) 0.42 (0.08-0.73) 0.23 (0.02-1.15) 0.306
ALB (g/dL) 3.0 (2.4-4.2) 3.5 (2.3-4.3) 0.218
TB (mg/dL) 1.3 (0.5-26.7) 1.4 (0.4-5.4) 0.548
AST (IU/L) 44 (20-85) 33 (14-156) 0.450
ALT (IU/L) 29 (10-53) 29 (8-73) 0.636
FBG (mg/dL) 97 (62-166) 129 (99-151) 0.079
IRI (μU/mL) 11.1 (3.5-107.3) 8.6 (4.5-14.5) 0.683
TC (mg/dL) 114 (102-177) 196 (87-377) 0.205
TG (mg/dL) 81 (23-114) 125 (80-314) 0.015
FFA (mEq/L) 0.77 (0.25-1.57) 0.53 (0.45-0.61) 0.277
BUN (mg/dL) 17 (5-44) 17 (4-66) 0.925
Cr (mg/dL) 0.79 (0.43-2.09) 0.58 (0.42-1.97) 0.549
Na (mEq/L) 137 (125-143) 137 (126-140) 0.751
K (mEq/L) 4.0 (3.3-4.9) 4.0 (3.3-4.9) 0.411
Cl (mEq/L) 104 (91-108) 103 (94-107) 1.000
Ca (mg/dL) 8.5 (8.2-9.3) 9.3 (8.6-9.8) 0.122
P (mg/dL) 3.3 (2.6-4.6) 3.1 (1.9-4.3) 0.793
PT (%) 60 (32-85) 66 (32-120) 0.284
NH3 (μg/dL) 77 (34-174) 91 (48-145) 1.000
BTR 2.98 (2.51-7.26) 5.47 (1.32-8.85) 0.275
History of alcohol intake (non- or light-drinker/drinker/unknown) 8/5/1 7/0/2 0.131
Diabetes mellitus (absent/present) 9/5 3/6 0.214
Hypertension (absent/present) 10/4 6/3 1.000
Esophageal varices (absent/present) 5/9 7/2 0.089
BCAA treatment (absent/present) 7/7 6/3 0.669
Table 4. Comparison of clinical features between patients who have a respiratory quotient less than 0.85 and patients who have a respi-
ratory quotient of 0.85 or more
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tended to be higher in patients who had an RQ less than
0.85 than in patients who had an RQ of 0.85 or more (Fig.
2). Patients with "HCV-related" cirrhosis were more com-
mon, and patients with autoimmune-related ("others") cir-
rhosis were less common in the group of RQ<0.85. Child-
Pugh grade and %REE were similar in patients who had an
RQ less than 0.85 and patients who had an RQ of 0.85 or
more.
Frequency of protein-energy malnutrition in patients with
liver cirrhosis
Of the 23 patients with liver cirrhosis, 11 patients
(47.8%) had an RQ less than 0.85 and serum ALB less than
3.5 g/dL, suggesting PEM (Table 5). The frequencies of pa-
tients with PEM were 25.0% (2 out of 8 patients) in Child-
Pugh grade A, 57.1% (4 out of 7 patients) in Child-Pugh
grade B, and 62.5% (5 out of 8 patients) in Child-Pugh
grade C.
Discussion
Resting energy expenditure, the amount of calories re-
quired by a body for a 24-hour period of inactivity (lying in
bed at rest in a comfortable environment), is a marker of
metabolic status. To eliminate the effects of age, sex, height,
and body weight on REE, the predicted REE is calculated
by the Harris-Benedict equations.17 A %REE (measured REE /
predicted REE) of more than 1.1 is usually considered to be
a hypermetabolic status.3 For example, %REE is reported to
increase in patients with cancer because the competition for
nutrients between the tumor and the host can lead to an ac-
celerated starvation state that promotes metabolic distur-
bances (alterations in carbohydrate, lipid, and protein me-
tabolism) in the host, including hypermetabolism, which
leads to decreased energy efficiency.18,19 The patients with
liver cirrhosis also showed some signs of PEM, but whether
increased basal or resting energy expenditure is a constant
feature remains controversial.1, 3, 12,20-22 Kato et al.1 reported
that the basal energy expenditure in liver cirrhosis was ele-
vated with decreased oxidation rates of carbohydrate and
protein and an increased oxidation rate of fat. They also re-
ported that REE was higher in patients with more advanced
disease such as Child-Pugh grades B and C.1 In the present
study, however, the median value of %REE was just 100%,
and there was no significant difference in %REE among
patients who were categorized as Child-Pugh grade A, B,
and C. Moreover, the median value of %REE was highest
in Child-Pugh grade A and lowest in grade C. The reason
for these discrepancies is unclear. Some of the possible ex-
planations would be heterogenous patients populations and
methodologic problems associated with the measurement of
energy expenditure because REE could not be accurately
predicted by using Harris-Benedict equations.19 In the cir-
rhotic patients with peripheral edema and/or ascites, the
predicted REE is sometimes over-estimated. In fact, 52.2%
of our patients (12 out of 23 patients) had ascites.
The RQ, the ratio of the volume of carbon dioxide pro-
duced to the volume of oxygen consumed during respira-
tion, is a useful marker to estimate energy metabolism and
10
Figure 1. Comparison of % resting energy expenditure and respi-
ratory quotient among patients who are categorized as Child-Pugh
grade A, B, and C
Figure 2. Comparison of serum triglyceride and free fatty acid
concentration between patients who have a respiratory quotient
less than 0.85 and patients who have a respiratory quotient of 0.85
or more







Table 5. Number and frequency of protein-energy malnutrition in
patients with liver cirrhosis
RQ, respiratory quotient.
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can be used to determine which nutrients are being used as
an energy source.11 During aerobic respiration, the respira-
tion of fat gives an RQ of 0.7, the respiration of protein
gives an RQ of 0.8, and the respiration of carbohydrate
gives an RQ of 1.0. Usually, the RQ ranges from 0.7 to 1.0
and averages around 0.82 in a healthy person. In cases of
liver cirrhosis, the RQ is reported to be lower than in
healthy subjects.7 Enhanced lipid oxidation and reduced
glucose oxidation can be responsible for the decrease in
RQ. Reduced glucose oxidation is due to the lower produc-
tion rate of glucose from glycogen, the decrease in periph-
eral glucose use, and the decrease in hepatic glycogen
stores.3 Kato et al.1 also reported that the basal oxidation
rate of fat was increased in patients with liver cirrhosis and
therefore, the RQ was significantly lower in patients with
liver cirrhosis than in healthy volunteers. In our present
study, the median value of RQ was 0.83 and there were no
significant differences in RQ among Child-Pugh grade A,
B, and C. However, the range of RQ tended to be highest
in Child-Pugh grade A and lowest in grade C, although
there were not statistically significant.
Tajika et al.3 reported that an RQ of 0.85 was the point
at which substrate for thermogenesis turned from carbohy-
drate dominant (RQ>0.85) to fat dominant (RQ<0.85), and
the survival rate was significantly lower in patients with
liver cirrhosis with a low RQ (<0.85) than in patients with
RQ scores above 0.85. Therefore, we conducted a compari-
son of clinical features between patients who had an RQ
less than 0.85 and patients who had an RQ of 0.85 or more.
As a result, Child-Pugh grade and %REE were similar in
patients who had an RQ less than 0.85 and patients who
had an RQ of 0.85 or more.
It is not surprising that there was a significant difference in
serum TC but not TG among patients who were categorized
as Child-Pugh grade A, B, and C. However, serum TG was
significantly lower in patients who had an RQ less than
0.85 than in patients who had an RQ of 0.85 or more, and
FFA tended to be higher in patients who had an RQ less
than 0.85 than in patients who had an RQ of 0.85 or more.
These results may suggest that serum TG concentration re-
flects the status of fat metabolism but not liver function,
and also, that the increase in FFA in liver cirrhosis might be
due to enhanced lipolysis. Plasma FFA oxidation rate has
been reported to increase in cirrhosis. This can suppress the
syntheses of TG and very low density lipoprotein (VLDL) in
liver, and therefore, decreases serum concentration of TG-
rich lipoproteins such as VLDL.23
Albumin synthesis appears to parallel liver function and
skeletal muscle protein synthesis is diminished in liver
cirrhosis.9 Normal protein nutrition state can be defined as
serum ALB concentrations above 3.5 g/dL.3 In the present
study, 78.3% of patients were in a state of protein and/or
energy malnutrition: 17.4% had protein malnutrition alone
(RQ of 0.85 or more and serum ALB of less than 3.5 g/dL),
13.0% had energy malnutrition alone (RQ of less than 0.85
and serum ALB of 3.5 g/dL or more), and 47.8% had PEM
(RQ of less than 0.85 and serum ALB of less than 3.5
g/dL). Our data were in line with the previously reported
results of Tajika et al.3 that 87% of patients with liver cir-
rhosis were in a state of either protein or energy malnutri-
tion. Moreover, PEM was more frequently observed at ad-
vanced stages of liver cirrhosis such as Child-Pugh grade B
(57.1%) and grade C (62.5%) than grade A (25.0%) in our
patients, as previously described.6, 8
In conclusion, our results revealed that %REE and RQ
were not associated with liver function, but the distribution
of RQ tended to be highest in Child-Pugh grade A and low-
est in grade C, suggesting that the oxidation rate of fat was
increased in advanced liver cirrhosis. Overall, 78.3% of pa-
tients were in a state of protein and/or energy malnutrition.
In our patients, 43.5% (10 out of 23 patients) received oral
BCAA treatment, particularly patients with Child-Pugh grade
C or an RQ less than 0.85. Oral supplementation with BCAA
is reported to be effective not only in treating hepatic
encephalopathy but also in improving protein malnutrition.1, 24
Because the PEM state in liver cirrhosis leads to a poor
prognosis, adequate nutritional support is very important.2
A longitudinal study in a large population is needed to de-
termine the efficacy of %REE and RQ measurements by in-
direct calorimetry for adequate nutritional treatment and
improvement of patient outcome.
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